ADAP
Adaptimmune Therapeutics
ADAP
ADAP
65 hedge funds and large institutions have $126M invested in Adaptimmune Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 10 closing their positions.
Holders
65
Holders Change
-4
Holders Change %
-5.8%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
18
Reduced
17
Closed
10
Calls
$11K
Puts
$28K
Net Calls
-$17K
Net Calls Change
-$94K